Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Polarean Imaging in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.05.
Current Consensus is
N/A
The current consensus among 0 contributing investment analysts is to n/a stock in Polarean Imaging. This N/A consensus rating has held steady for over two years.
Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. Its research equipment includes HPX hyperpolarizer, HPX measurement station, HPX gas manifold, chest coil, and dose delivery bags. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.
Read More